Biblio

11 resultats trouvés
Filtres: Mot-clé is IL-23  [Clear All Filters]
A
Wendling D.  2016.  An overview of investigational new drugs for treating ankylosing spondylitis. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 25:95-104.
B
Toussirot E.  2015.  Biologics in spondyloarthritis: TNF alpha inhibitors and other agents. IMMUNOTHERAPY. 7:669-681.
C
Toussirot E, Bereau M, Vauchy C, Saas P.  2018.  Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence FRONTIERS IN PHYSIOLOGY. 9:440.
E
Wendling D, Prati C, Chouk M, Verhoeven F.  2020.  Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism? JOINT BONE SPINE. 87:5-7.
I
Wendling D, Aubin F, Verhoeven F, Prati C.  2017.  IL-23/Th17 targeted therapies in SAPHO syndrome. A case series. JOINT BONE SPINE. 84:733-735.
Wendling D.  2015.  Interleukin-17 targeted therapies in axial spondyloarthritis. IMMUNOTHERAPY. 7:1125-1128.
N
Toussirot E.  2017.  New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents. EXPERT OPINION ON PHARMACOTHERAPY. 18:275-282.
P
Bellanger A-P, Gbaguidi-Haore H, Gondoin A, Pallandre J-R, Vacheyrou M, Valot B, Soumagne T, Reboux G, Dalphin J-C, Millon L.  2016.  Positive fungal quantitative PCR and Th17 cytokine detection in bronchoalveolar lavage fluids: Complementary biomarkers of hypersensitivity pneumonitis? JOURNAL OF IMMUNOLOGICAL METHODS. 434:61-65.
S
Wendling D, Vuitton L, Koch S, Prati C.  2015.  Spondyloarthritis and the gut: A new look. JOINT BONE SPINE. 82:77-79.
T
Wendling D.  2016.  The gut in spondyloarthritis. JOINT BONE SPINE. 83:401-405.
V
Guillot X, Prati C, Wendling D.  2014.  Vitamin D and spondyloarthritis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 10:1581-1589.